ANIP - ANI PHARMACEUTICALS INC

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 88.74

Open

$ 88.08

Bid

$ 77.51 x 7

Ask

$ 93.50 x 200

Day's Range

$ 87.60 - $ 89.31

52 Week Range

$ 52.50 - $ 99.50

Volume

180,142

Average Volume

Market Cap

1.93B

Beta (5Y Monthly)

$ 0.73

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2025	06-30-2025	10-Q
2	05-09-2025	03-31-2025	10-Q
3	02-28-2025	01-01-1970	10-K
4	11-08-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-10-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	03-09-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-15-2022	12-31-2021	10-K
16	11-01-2021	09-30-2021	10-Q
17	08-06-2021	06-30-2021	10-Q
18	05-07-2021	03-31-2021	10-Q
19	03-11-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-27-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	02-27-2019	12-31-2018	10-K
28	11-06-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	02-27-2018	12-31-2017	10-K
32	11-02-2017	09-30-2017	10-Q
33	08-03-2017	06-30-2017	10-Q
34	05-04-2017	03-31-2017	10-Q
35	03-02-2017	12-31-2016	10-K
36	11-03-2016	09-30-2016	10-Q
37	08-04-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	02-23-2016	12-31-2015	10-K
40	11-03-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Truist Securities Maintains Hold on ANI Ph...
10/09/2025 14:41:42

Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and raises the price target...

6 Analysts Have This To Say About ANI Phar...
09/24/2025 13:01:29

JP Morgan Maintains Overweight on ANI Phar...
09/24/2025 12:23:27

JP Morgan analyst Ekaterina Knyazkova maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Overweight and raises the price tar...

HC Wainwright & Co. Maintains Buy on ANI P...
09/17/2025 14:36:45

HC Wainwright & Co. analyst Brandon Folkes maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price t...

4 Analysts Have This To Say About ANI Phar...
09/08/2025 20:00:28

Guggenheim Maintains Buy on ANI Pharmaceut...
09/08/2025 13:43:26

Guggenheim analyst Vamil Divan maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price target from $86 t...

Truist Securities Maintains Hold on ANI Ph...
08/11/2025 13:18:18

Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and raises the price target...

HC Wainwright & Co. Maintains Buy on ANI P...
08/08/2025 18:57:07

HC Wainwright & Co. analyst Brandon Folkes maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price t...

12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

ANI Pharmaceuticals Raises FY2025 Adj EPS ...
08/08/2025 10:52:56

Full Year 2025 Guidance:Full Year 2025GuidancePrevious Full Year 2025Guidance2024 ActualGrowth Net Revenue (Total Company)$818 ...

ANI Pharmaceuticals Q2 2025 Adj. EPS $1.80...
08/08/2025 10:51:06

Earnings Scheduled For August 8, 2025
08/08/2025 08:32:13

Earnings Preview For ANI Pharmaceuticals
08/07/2025 15:04:36

Delaware Court Gives Unanimous Verdict Det...
07/29/2025 20:24:44

CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a po...

ANI Pharma's ILUVIEN Cuts Injections for D...
07/23/2025 10:51:41

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced results from the NEW DAY clinical trial of ILUVIEN...

HC Wainwright & Co. Initiates Coverage On ...
07/10/2025 10:27:33

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy rating and...

top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-this-quarter

Top 3 Health Care Stocks That Could Lead T...
05/27/2025 11:20:19

ANI Pharma Launches Phase 4 Trial to Test ...
05/22/2025 10:51:34

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ: ANIP) today announced the initiation of a Phase 4 clinical trial at Mas...

Guggenheim Reiterates Buy on ANI Pharmaceu...
05/12/2025 14:28:09

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $86 price target.

cortrophin-demand-is-soaring-for-ani-pharma-ceo-says-well-positioned-to-mitigate-potential-tariff-impact

Cortrophin Demand Is Soaring For ANI Pharm...
05/09/2025 16:07:00

ANI Pharmaceuticals Q1 revenue rose 43.4% to $197.12 million, EPS beat consensus, and 2025 guidance was raised on strong Cortro...